<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0">
<channel>
<title>AAO 2016 Ophthalmic technology event - news, content powered by VPO and PR Newswire</title>
<link>https://aao.vporoom.com/</link>
<description></description>
<item>
<title>Avisi Technologies Announces Positive Twelve-Month Clinical Data of VisiPlate® Aqueous Shunt at AAO 2025</title>
<link>https://aao.vporoom.com/2025-11-03-Avisi-Technologies-Announces-Positive-Twelve-Month-Clinical-Data-of-VisiPlate-R-Aqueous-Shunt-at-AAO-2025</link>
<description></description>
<pubDate>Mon, 03 Nov 2025 10:00:00 -0500</pubDate>
<guid>https://aao.vporoom.com/2025-11-03-Avisi-Technologies-Announces-Positive-Twelve-Month-Clinical-Data-of-VisiPlate-R-Aqueous-Shunt-at-AAO-2025</guid>
</item>
<item>
<title>ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization</title>
<link>https://aao.vporoom.com/2025-10-07-ZEISS-expands-DORC-portfolio-and-further-strengthens-digital-footprint-with-improved-workflow-efficiency-and-digital-visualization</link>
<description></description>
<pubDate>Tue, 07 Oct 2025 09:00:00 -0400</pubDate>
<guid>https://aao.vporoom.com/2025-10-07-ZEISS-expands-DORC-portfolio-and-further-strengthens-digital-footprint-with-improved-workflow-efficiency-and-digital-visualization</guid>
<enclosure url="https://mma.prnewswire.com/media/2790317/Carl_Zeiss_Meditec_AG_New_Midfield_endoillumination_light_probe_with_directed_light.jpg?p=thumbnail" type="image/jpeg" />
</item>
<item>
<title>Avirmax Biopharma Inc. to Exhibit Development of Next Generation Gene Therapies for Ocular Diseases at the AAO 2024 Annual Meeting in Chicago</title>
<link>https://aao.vporoom.com/2024-10-15-Avirmax-Biopharma-Inc-to-Exhibit-Development-of-Next-Generation-Gene-Therapies-for-Ocular-Diseases-at-the-AAO-2024-Annual-Meeting-in-Chicago</link>
<description></description>
<pubDate>Tue, 15 Oct 2024 20:00:00 -0400</pubDate>
<guid>https://aao.vporoom.com/2024-10-15-Avirmax-Biopharma-Inc-to-Exhibit-Development-of-Next-Generation-Gene-Therapies-for-Ocular-Diseases-at-the-AAO-2024-Annual-Meeting-in-Chicago</guid>
</item>
<item>
<title>Nanoscope Announces Presentations at the American Academy of Ophthalmology Annual Meeting 2024</title>
<link>https://aao.vporoom.com/2024-10-15-Nanoscope-Announces-Presentations-at-the-American-Academy-of-Ophthalmology-Annual-Meeting-2024</link>
<description></description>
<pubDate>Tue, 15 Oct 2024 07:00:00 -0400</pubDate>
<guid>https://aao.vporoom.com/2024-10-15-Nanoscope-Announces-Presentations-at-the-American-Academy-of-Ophthalmology-Annual-Meeting-2024</guid>
</item>
<item>
<title>Innovent Presents Clinical Data of Two Ophthalmic Bispecific Antibodies IBI302 (anti-VEGF/complement) and IBI324 (anti-VEGF-A/Ang-2) at American Academy of Ophthalmology (AAO) Annual Meeting 2023</title>
<link>https://aao.vporoom.com/2023-11-05-Innovent-Presents-Clinical-Data-of-Two-Ophthalmic-Bispecific-Antibodies-IBI302-anti-VEGF-complement-and-IBI324-anti-VEGF-A-Ang-2-at-American-Academy-of-Ophthalmology-AAO-Annual-Meeting-2023</link>
<description></description>
<pubDate>Sun, 05 Nov 2023 19:00:00 -0500</pubDate>
<guid>https://aao.vporoom.com/2023-11-05-Innovent-Presents-Clinical-Data-of-Two-Ophthalmic-Bispecific-Antibodies-IBI302-anti-VEGF-complement-and-IBI324-anti-VEGF-A-Ang-2-at-American-Academy-of-Ophthalmology-AAO-Annual-Meeting-2023</guid>
</item>
</channel>
</rss>
